MAPI Research Trust provides reliable, comprehensive and up-to-date information services to research scientists, pharmaceutical companies, and governmental health agencies involved in the fields of Patient-Reported Outcomes (PRO) and Pharmaco-Epidemiology worldwide.
Home SERVICES Questionnaire Licensing
INQoL (Individualized Neuromuscular Quality of Life Questionnaire) PDF Print E-mail

Version 1.2

Developed by:
Kelly Vincent, Alison Carr and Michael Rose (UK)

Objective:
To assess health-related quality of life of patient suffering from neuromuscular diseases.

Copyright:
INQoL © 2005 M R Rose & King’s College NHS-Trust, All rights reserved.

Reference Publications:
Construction and validation of a quality of life questionnaire for neuromuscular disease (INQoL). Vincent KA, Carr AJ, Walburn J, Scott DL, Rose MR. Neurology, March 2007 (In Press).

Validation of a quality of life measure for myasthenia gravis. Rose M, Brooks V, Walburn J, Sanders D, Pandya S, Kissel J et al. Neuromuscular Disorders 2006; 16 supplement: S152 (Abstract).

Rose M, Brooks V, Walburn J, Sanders D, Pandya S, Kissel J et al. Validation of the UK Individualised Neuromuscular Quality of Life measure for use in the USA. Neuromuscular Disorders 2006; 16 supplement: S176 (Abstract).



Conditions of use:

1. User Agreement:

carre6 Existing translations: User is required to complete and sign a User Agreement in which specific conditions required by the copyright owners are detailed.

carre6 New translation(s): in addition to the User Agreement, User is required to complete and sign a Translation Agreement.

2. Access fees:

carre6 Author's royalty fee :

- The use of the INQoL in commercial studies is subject to Dr. Michael Rose's royalty fee, of an amount of 
   500 €* per study and per language version
- The use of the INQoL in academic research and individual clinical practice is free from author's royalty fee.

Other specific conditions requested by the author are detailed in the User Agreement.

carre6 Distribution fees are requested according to the study design and context of use of the questionnaire:

- In not-funded academic research (1) and individual clinical practice: free of charge
- In funded academic research (2): 300 €* per study + 50 €* per language version
- In commercial studies (3) involving "for-profit" organizations: 500 €* per study + 150 €* per language version

* excluding VAT

(1) Not funded academic research: if the project is not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds then fees are waived.

(2) Funded academic research: projects receiving funding from commerce, government, EU should anticipate paying the corresponding fees.

(3) Commercial studies (industry, CRO, any for-profit companies).

Review copy:

Original UK English version available for review purpose only. Please click here to access.

Contact information:

MAPI Research Trust
Christelle Berne

27 rue de la Villette
F - 69003 LYON
Tel: +33 4 72 13 65 75
Fax: +33 4 72 13 66 82

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Please have the User Agreement and/or Translation Agreement completed, dated and signed and return one original copy to MAPI Research Trust by post. As soon as we receive it, we will process your request.

More information on INQoL on PROQOLID

[ BACK ]

 

New questionnaires distributed by MAPI Research Trust

ADCPQ (Alzheimer’s Disease Caregiver Preference Questionnaire)  
Novartis Pharmaceuticals Corporation (USA)

FIS (Fatigue Impact Scale)
D-FIS (Daily Fatigue Impact Scale)
John Fisk (Canada)  

HIV-SQUAD (Symptom Quality of Life Adherence) Questionnaire ®
Abbott France (France) 

MOS-HIV (Medical Outcome Study-HIV Health Survey)
Albert Wu (USA)

MPQ (McGill Pain Questionnaire)
Ronald Melzack (Canada)

MPQ-SF (McGill Pain Questionnaire - Short Form)
Ronald Melzack (Canada)

Nausea Questionnaire 
Ronald Melzack (Canada)

ODI (Oswestry Disability Questionnaire)
Jeremy Fairbank (UK)

PHQ (Patient Health Questionnaire Screeners
Pfizer Inc. (USA)

PRAC-Test (PRAgmatic Content and face validity Test)
Mapi Values (France)

SF-MPQ-2 (Short-form McGill Pain Questionnaire)
Ronald Melzack (Canada) and IMMPACT (USA) 


To access our catalog, please click here.



Coming soon!

Crohn and Anti-tnf Treatment Satisfaction questionnaire
Abbott France (France)


For any information, please contact:
contact@mapi-trust.org